| Ytd | 7.67% | |
| 1y | 33.16% |
| Open | 864.34 | Prev Close | 871.38 | Low | 864.32 | High | 885.63 | Mkt Cap | 101.95B |
| Vol | 724.74K | Avg Vol | 1.17M | EPS | 40.82 | P/E | 21.33 | Forward P/E | 18.98 |
| Beta | 0.30 | Short Ratio | 3.68 | Inst. Own | 95.33% | Dividend | 3.28 | Div Yield | 0.39 |
| Ex Div Date | 09-01 | Earning | 08-05 | 50-d Avg | 791.51 | 200-d Avg | 836.10 | 1yr Est | 945.47 |
MCK News
McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty grow
McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand,
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
These healthcare giants can deliver steady gains.
Revenue: $105.4 billion, an increase of 8% year over year.Adjusted Earnings Per Share: $9.93, an inc
McKesson Corporation (MCK) Q1 2027 Earnings Call Transcript
McKesson (MCK) came out with quarterly earnings of $9.93 per share, beating the Zacks Consensus Esti
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter e
Drug distributor McKesson on Wednesday raised its annual profit forecast after beating first-quarter
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2027 first
A few sectors have dominated the market this year, and healthcare isn't one of them. Many stocks in
McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs,
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
McKesson heads into Q1 with AI-driven efficiency, specialty momentum and oncology growth in focus as
Get a deeper insight into the potential performance of McKesson (MCK) for the quarter ended June 202
In the most recent trading session, McKesson (MCK) closed at $865.51, indicating a -2.59% shift from
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations
Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price
Dimensional Fund Advisors LP grew its stake in shares of McKesson Corporation (NYSE: MCK) by 1.2% in
In the most recent trading session, McKesson (MCK) closed at $814.04, indicating a -1.79% shift from
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhi
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $
TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and lowers the price targ
July 8, 2026 records indicate that Representative Ritchie Torres filed a purchase of McKesson (NYSE:
Nasdaq jumps 1.6% to record highs Friday as semiconductor rally and stronger-than-expected April pay
